Drugs / OPA-6566
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01410188 | Sep 2011 → Oct 2012 | ocular hypertension, open-angle glaucoma | Kubota Vision Inc. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2010-09-27 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Otsuka Pharmaceutical and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma otsuka.co.jp ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPA-6566 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01410188 ↗ |
| Route | Topical | “OPA-6566 ophthalmic solution” NCT01410188 ↗ |